2. Signaling Pathways
  3. Others
  4. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (9621):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-169984S
    Tyk2-IN-22-d3
    Tyk2-IN-22-d3 (Compound 1) is the deuterated analog of Tyk2-IN-22 (HY-168339). Tyk2-IN-22 (Compound A8) is a selective inhibitor for tyrosine kinase 2 (Tyk2), that it inhibits Tyk2, JAK1, and JAK3 with IC50s of 9.7, 148.6, and 883.3 nM, respectively. Tyk2-IN-22 inhibits the downstream STAT5 phosphorylation.
    Tyk2-IN-22-d<sub>3</sub>
  • HY-W010537S
    3-Chloropyridine-d4
    3-Chloropyridine-d4 is the deuterium labeled 3-Chloropyridine.
    3-Chloropyridine-d<sub>4</sub>
  • HY-W739948
    Naltrexone-d3
    Naltrexone-d3 is a deuterated labeled Naltrexone (HY-76711). Naltrexone is an antagonist of Opioid receptor. Naltrexone inhibits cell proliferation in vivo. Naltrexone reduces tumor growth by interfering with cell signalling and modifying the immune system.
    Naltrexone-d<sub>3</sub>
  • HY-W745885
    2-(5-tert-Butyl-2-hydroxyphenyl)benzotriazole-d9
    2-(5-tert-Butyl-2-hydroxyphenyl)benzotriazole-d9 (2-(2H-Benzo[d][1,2,3]triazol-2-yl)-4-(tert-butyl)phenol-d9) is the deuterium labeled 2-(2H-Benzo[d][1,2,3]triazol-2-yl)-4-(tert-butyl)phenol (HY-W440436).
    2-(5-tert-Butyl-2-hydroxyphenyl)benzotriazole-d<sub>9</sub>
  • HY-W777774
    a-(Benzoylamino)benzeneacetamide-d10
    a-(Benzoylamino)benzeneacetamide-d10 is the deuterium labeled a-(Benzoylamino)benzeneacetamide.
    a-(Benzoylamino)benzeneacetamide-d<sub>10</sub>
  • HY-141629S
    N-Palmitoyl-D-sphingomyelin-d31
    N-Palmitoyl-D-sphingomyelin-d31 is deuterium labeled N-Palmitoyl-D-sphingomyelin.
    N-Palmitoyl-D-sphingomyelin-d<sub>31</sub>
  • HY-W756434
    Desphenyl tenofovir alafenamide ammonium-d7
    Desphenyl tenofovir alafenamide ammonium-d7 is the deuterium labeled Desphenyl tenofovir alafenamide ammonium.
    Desphenyl tenofovir alafenamide ammonium-d<sub>7</sub>
  • HY-W778008
    Rac-Vigabatrin-13C,d2
    Rac-Vigabatrin-13C,d2 (Major) is the deuterium and 13C labeled Vigabatrin (HY-15399). Vigabatrin (γ-Vinyl-GABA), an inhibitory neurotransmitter GABA vinyl-derivative, is an orally active and irreversible GABA transaminase inhibitor. Vigabatrin is an antiepileptic agent, which acts by increasing GABA levels in the brain by inhibiting the catabolism of GABA by GABA transaminase.
    Rac-Vigabatrin-<sup>13</sup>C,d<sub>2</sub>
  • HY-W415090S
    Orange OT-d6
    Orange OT-d6 is a deuterated labeled Orange OT.
    Orange OT-d<sub>6</sub>
  • HY-W768684
    5b-Androst-16-en-3a-ol-d
    5b-Androst-16-en-3a-ol-d5 is the deuterium labeled 5β-Androst-16-en-3α-ol (HY-W779114).
    5b-Androst-16-en-3a-ol-d
  • HY-137215S1
    4-cis-Hydroxy Cilostazol-d5
    4-cis-Hydroxy Cilostazol-d5 is the deuterium labeled 4'-trans-Hydroxy Cilostazol[1].
    4-cis-Hydroxy Cilostazol-d<sub>5</sub>
  • HY-125771S
    1-Stearoyl-sn-glycero-3-phosphocholine-d35
    1-Stearoyl-sn-glycero-3-phosphocholine-d35 is deuterium labeled 1-Stearoyl-sn-glycero-3-phosphocholine (HY-125771). 1-Stearoyl-sn-glycero-3-phosphocholine is a lysophosphatidylcholine that inhibits HDAC3 activity and phosphorylation of STAT3 in K562 cells. 1-Stearoyl-sn-glycero-3-phosphocholine induces apoptosis and exhibits anticancer activity in chronic myelogenous leukemia (CML) K562 cells.
    1-Stearoyl-sn-glycero-3-phosphocholine-d<sub>35</sub>
  • HY-41494S1
    o-Toluic acid-13C
    o-Toluic acid-13C is the 13C labeled o-Toluic acid. o-Toluic acid (2-Methylbenzoic acid) is a benzoic acid substituted by a methyl group at position 2. O-Toluic acid plays a role as a xenobiotic metabolite.
    o-Toluic acid-<sup>13</sup>C
  • HY-143953S
    Estrone ß-D-Glucuronide-d4 lithium
    Estrone ?-D-Glucuronide-d4 (lithium) is the deuterium labeled Estrone ?-D-Glucuronide.
    Estrone ß-D-Glucuronide-d<sub>4</sub> lithium
  • HY-W750442
    4-Bromophenoxytriisopropylsilane-13C6
    4-Bromophenoxytriisopropylsilane-13C6 is the 13C-labeled (4-Bromophenoxy)triisopropylsilane (HY-W702226).
    4-Bromophenoxytriisopropylsilane-<sup>13</sup>C<sub>6</sub>
  • HY-W710400
    Quifenadine-d10
    Quifenadine-d10 is the deuterium labeled Quifenadine (HY-122761). Quifenadine (Compound 3a), the hydroxyl-(diphenyl)methyl quinuclidine derivative, is a M3 receptor antagonist with an IC50 value > 1000 nM. Quifenadine can be used for the research of neurological disease.
    Quifenadine-d<sub>10</sub>
  • HY-163165S
    16:0-19:2-16:0 TG-d5
    16:0-19:2-16:0 TG-d5 is the deuterium labeled triacylglycerols.
    16:0-19:2-16:0 TG-d<sub>5</sub>
  • HY-W319671S
    2-Methoxy-4,5-dihydro-1H-imidazole-d4
    2-Methoxy-4,5-dihydro-1H-imidazole-d4 is the deuterium labeled 2-Methoxy-4,5-dihydro-1H-imidazole.
    2-Methoxy-4,5-dihydro-1H-imidazole-d<sub>4</sub>
  • HY-G0002S
    Lurasidone Metabolite 14326-d8
    Lurasidone Metabolite 14326-d8 is the deuterium labeled Lurasidone Metabolite 14326, which is a metabolite of Lurasidone.
    Lurasidone Metabolite 14326-d<sub>8</sub>
  • HY-14538S3
    Haloperidol-13C6
    Haloperidol-13C6 is the 13C6 labeled Haloperidol. Haloperidol is a potent dopamine D2 receptor antagonist, widely used as an antipsychotic.
    Haloperidol-<sup>13</sup>C<sub>6</sub>